Helen Bourne

BBus (Acc), CPA, MBA, MAICD. Chief Financial Officer. Helen is responsible for Finance and Information Technology providing strategic oversight across governance, financial control, reporting, risk management, strategic planning and IT services. Helen has over 15 years of senior leadership experience in both multinational businesses and Australian owned companies, across a diverse range of industries including FMCG, publishing, telecommunications and infrastructure. Her expertise spans financial management, corporate governance, strategic design, enterprise systems and team leadership. Her previous roles include Chief Financial Officer and Company Secretary at Botany Group, along with executive finance and strategy leadership roles at Allen & Unwin, Murrumbidgee Irrigation, George Westons Foods and Optus.

Meelian Hoh

Meelian Hoh is the Chief Executive Officer of Key Pharmaceuticals. She is responsible for setting and executing the company’s strategic direction, driving sustainable growth, leading organisational transformation, and fostering a high-performance culture. She works closely with the Board and executive team to ensure the business continues to deliver strong commercial outcomes while investing in future growth opportunities.

With more than 30 years of experience across healthcare, technology and fast-moving consumer goods (FMCG) industries throughout Australia and the Asia Pacific region, Meelian has built a reputation for successfully leading business growth, transformation programs, strategic planning and company turnarounds. Her career has focused on helping organisations identify growth opportunities, improve performance, navigate change, and create long-term value for stakeholders.

Before being appointed CEO, Meelian served as Chief Financial Officer and Chief Operating Officer at Key Pharmaceuticals, where she played a pivotal role in strengthening the company’s strategic foundations, operational capabilities and growth agenda.

Prior to joining Key Pharmaceuticals, Meelian held senior leadership roles with Smith & Nephew, George Clinical, Mitel Asia Pacific, KinCare Group and Novartis Pharmaceuticals.

Nick Boyden

BA (International Relations) Nick is responsible for Marketing and Innovation, Corporate brand and Innovation. Nick has over 20 years of marketing experience in several multinational FMCGs. Nicks background is a blend of global, local FMCG and Consumer Healthcare marketing, specialising in range of areas with focus on building brands, full end-to-end marketing, brand strategy/positioning, innovation and communication development with a strong underpinning in commercial brand management.

Previous roles include Global Brand Head Centrum (GSK/Haleon), Marketing Director ANZ  (GSK CH/Haleon), Global Brand Director Unilever PLC and Head of Marketing ANZ Cerebos-Suntory.

Jacqueline Thorn

BSc (Hons), PhD, MBA, GDip IP. Chief of Staff & Privacy Officer.

Jacqueline is responsible for Legal and Contracts, Privacy, Risk, ESG and supporting the CEO. Jacqueline has 30 years’ experience in commercial operations, including business development and intellectual property in the biotechnology, pharmaceutical and clinical research industries.

Jacqueline’s previous experience includes Commercial Director & Country Head ANZ at George Clinical as well as holding Sales and Marketing positions at Bayer Schering Pharma, Oxoid and Dupont.

Michelle Fry

BA (Psychology). Head of People and Culture. Michelle is responsible for developing and leading strategy for People and Culture. A People & Culture leader with over 20 years’ experience at Sanofi driving business transformation across Australia, New Zealand, Korea and Japan.

She is known for her ability to align people strategy with commercial outcomes. Michelle partners closely with executive teams to lift performance, simplify systems, and embed inclusive, high-impact ways of working. Her leadership has helped organisations achieve double-digit growth, industry-leading engagement, and award-winning recognition as a Best Place to Work. Whether introducing AI-enabled coaching, accelerating talent mobility, or streamlining operations, Michelle brings clarity, empathy and a sharp focus on delivering results through people.

Thomas Press

BComm, Director of Sales. Tom leads the Category, National Accounts, and Field Teams at Key Pharmaceuticals, with responsibility for developing and executing integrated commercial strategies across all channels and market segments. A results-driven sales leader, Tom has a strong track record of accelerating business growth, building high-performing teams, strengthening customer partnerships, and delivering sustainable commercial success in highly competitive and fast-paced markets.

Tom brings extensive international experience across Australia, Vietnam, Thailand, and New Zealand, spanning the FMCG, Technology, Consumer Healthcare, and Pharmaceutical sectors. Throughout his career, he has held senior leadership roles including Sales Director at Microsoft ANZ, Sales Director at Johnson & Johnson (Kenvue) ANZ, Customer Development Director at Unilever, and Head of Key Accounts at Danone Nutricia. His broad industry expertise, strategic mindset, and passion for people leadership have consistently enabled organizations to achieve commercial excellence and market-leading results.

Trevor Juniper

BA, MBA. Trevor is responsible for Business Development including new business acquisitions, Public Relations and Corporate Communications, business planning processes and strategic projects management.

Trevor has over 30 years of general management, business development and marketing experience in local Australian, APAC regional and global roles. His experience spans consumer healthcare, pharmaceuticals and biotechnology, developing and implementing business building opportunities, partnerships and team leadership.

His previous roles include general management and senior marketing assignments in China, Canada and Australia, category director Nicorette in global marketing at Pharmacia, APAC regional marketing positions at Schering-Plough and Bausch & Lomb and business development at BioInvent, a Swedish biotechnology company.

Feryal de Belin

BSc (Chem Hons), Master of Pharmaceutical Medicine. Director of Scientific Affairs. Feryal is responsible for the Quality Assurance, Regulatory Affairs, Medical Affairs and Pharmacovigilance functions.  With more than 25 years of experience spanning the pharmaceutical, medical device, veterinary, and cosmetic sectors across both Australian and international markets, Feryal brings a wealth of expertise in sterile and non-sterile manufacturing of medicines and medical devices.

Her background includes managing global compliance strategies, implementing GMP-compliant Quality Systems, leading successful Regulatory and Notified Body audits, and directing complex regulatory submissions and technology transfers.

Her leadership roles have included Regional Head of Technical & Regulatory APME and South Africa at Care Pharmaceuticals, Head of Quality at Troy Animal Healthcare, Technical Affairs Manager at Avon, Regulatory & Quality Manager at Medical Australia (formerly) TUTA Healthcare, and Quality, Technical, and Regulatory roles at AstraZeneca.